Literature DB >> 8343768

Management of heparin induced thrombocytopenia.

H N Magnani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8343768      PMCID： PMC1678357          DOI： 10.1136/bmj.307.6897.203-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Pharmacology and mechanism of action of ancrod: potential for inducing thrombosis.

Authors:  C Krishnamurti; C D Bolan; T J Reid; B M Alving
Journal:  Blood       Date:  1992-05-01       Impact factor: 22.113

2.  Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

Authors:  B H Chong; F Ismail; J Cade; A S Gallus; S Gordon; C N Chesterman
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

3.  Uses of heparin. Ancrod for heparin induced thrombocytopenia.

Authors:  R L Soutar; J S Ginsberg
Journal:  BMJ       Date:  1993-05-22

4.  Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia.

Authors:  C Demers; J S Ginsberg; P Brill-Edwards; A Panju; T E Warkentin; D R Anderson; C Turner; J G Kelton
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113
  4 in total
  1 in total

Review 1.  [Heparin induced thrombocytopenia. A frequently unrecognised complication after major orthopedic surgery].

Authors:  S M Picker; B S Gathof
Journal:  Orthopade       Date:  2004-11       Impact factor: 1.087
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.